VitaNova Life Sciences Corp (VNOV) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

$2.7M

Net Income/Loss (FY2024)

$850.7K

Total Assets (FY2024)

$2.3M

Total Equity (FY2024)

$1.9M

Cash Flows from Operating Activities (FY2024)

$192.8K

Source: VitaNova Life Sciences Corp 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.